蛍光in situハイブリダイゼーションプローブ市場 - 世界の産業規模、シェア、動向、機会、予測、技術別、タイプ別（DNA、RNA）、用途別、最終用途別、地域別、競合別、2020年～2030年

蛍光in situハイブリダイゼーションプローブの世界市場規模は2024年に9億8,150万米ドルとなり、2030年までのCAGRは6.45%で、予測期間中に目覚ましい成長が予測されています。

蛍光in situハイブリダイゼーション（FISH）プローブの世界市場は、腫瘍学、希少疾患研究、細胞遺伝学などにおける高精度のゲノム診断に対する需要の高まりに後押しされ、急拡大しています。この市場は、無傷の細胞または組織サンプル内の特定のDNAまたはRNA配列を検出し、局在化するように設計されたFISHプローブ専門の分子ツールの開発、製造、商業化を包含します。

FISHプローブは染色体異常、遺伝子増幅、欠失、転座の同定に不可欠であり、臨床診断とトランスレーショナルリサーチの両分野で欠かせないものとなっています。腫瘍学では、FISHプローブは、乳がんにおけるHER2遺伝子の増幅や肺がんにおけるALK遺伝子の再配列の同定など、標的治療の決定をサポートするために日常的に使用されています。その役割は、出生前診断、血液悪性腫瘍の評価、次世代シーケンシングプラットフォームの結果の検証においても同様に重要です。

市場開拓はまた、特に精密医療とバイオマーカーに基づく医薬品開発が普及するにつれて、学術・製薬研究開発での採用が増加することによっても推進されています。さらに、自動画像処理システムとAI主導の解釈の統合により、スループットが加速し、解析時間が短縮され、FISHベースのアッセイの臨床的有用性と商業的実行可能性が高まっています。

主要な市場促進要因

ゲノム研究の進展

主要な市場課題

競合市場力学

主要な市場動向

非侵襲的出生前検査（NIPT）におけるアプリケーションの拡大

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（Q FISH、FLOW FISH、その他）
  • タイプ別（DNA、RNA（mRNA、miRNA、その他））
  • 用途別（がん研究、遺伝性疾患、その他）
  • 最終用途別（研究、臨床、コンパニオン診断）
  • 地域別
  • 企業別（2024年）
• 製品市場マップ

第6章 北米の蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋の蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの蛍光in situハイブリダイゼーションプローブ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Thermo Fisher Scientific Inc.
• PerkinElmer Health Sciences Inc
• Biodot Inc
• New Horizons Diagnostic Corp
• Merck KGaA
• Agilent Technologies, Inc.
• Abnova Corp.
• Genemed Biotechnologies Inc
• F. Hoffmann-La Roche Ltd
• Oxford Gene Technology Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Fluorescent In Situ Hybridization Probe Market was valued at USD 981.50 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2030. The Global Fluorescent In Situ Hybridization (FISH) Probe Market is undergoing rapid expansion, fueled by the rising demand for high-precision genomic diagnostics across oncology, rare disease research, and cytogenetics. This market encompasses the development, manufacturing, and commercialization of FISH probes specialized molecular tools designed to detect and localize specific DNA or RNA sequences within intact cells or tissue samples.

These probes are essential for identifying chromosomal abnormalities, gene amplifications, deletions, or translocations, making them indispensable in both clinical diagnostics and translational research. In oncology, FISH probes are routinely deployed to support targeted therapy decisions, such as identifying HER2 gene amplification in breast cancer or ALK gene rearrangements in lung cancer. Their role is equally critical in prenatal diagnostics, hematologic malignancy evaluation, and in validating results from next-generation sequencing platforms.

Market growth is also being driven by increased adoption in academic and pharmaceutical R&D, particularly as precision medicine and biomarker-based drug development gain traction. Further, the integration of automated imaging systems with AI-driven interpretation is accelerating throughput and reducing analysis time, enhancing the clinical utility and commercial viability of FISH-based assays.

Key Market Drivers

Advancements in Genomic Research

Advancements in genomic research have revolutionized our understanding of genetics, enabling breakthroughs in disease diagnosis, treatment, and prevention. One of the key technologies driving progress in this field is Fluorescent In Situ Hybridization (FISH), which allows researchers to visualize and locate specific DNA sequences within cells. As genomic research continues to evolve, so does the demand for FISH probes, making them a pivotal component of the Global FISH Probe Market. The sequencing of the human genome marked a monumental achievement in the field of genomics. It provided researchers with a comprehensive map of our genetic makeup, comprising over 20,000 protein-coding genes. However, understanding the functions and interactions of these genes requires tools like FISH probes to visualize their activity within cells. As genomics delves deeper into gene function, the demand for FISH probes increases. Genomic research has been instrumental in identifying genetic mutations that cause diseases. Whether it's rare genetic disorders or common ailments like cancer, researchers are increasingly using FISH probes to pinpoint specific mutations within the genome. This has significant implications for diagnosis, prognosis, and targeted therapies, driving the need for more advanced FISH probes. Advancements in genomics have ushered in the era of personalized medicine. By analyzing an individual's genetic profile, clinicians can tailor treatments to a patient's unique genetic makeup. FISH probes play a critical role in this process by helping identify specific genetic markers and abnormalities.

As personalized medicine gains traction, so does the demand for FISH probes that enable precise genetic analysis. Genomic research has revealed the genetic underpinnings of complex diseases like Alzheimer's, diabetes, and heart disease. Investigating these conditions often requires an in-depth understanding of genetic variations and gene expression patterns. FISH probes provide researchers with the tools to study these complexities at the cellular level, advancing our knowledge of disease mechanisms and potential therapeutic targets. The pharmaceutical industry heavily relies on genomic research to discover new drug targets and develop precision medicines. FISH probes are essential in validating potential drug targets by confirming the presence or absence of specific genetic markers in cellular models. This accelerates drug development and fuels the demand for FISH probes in research and development. Both academic research institutions and clinical laboratories benefit from advancements in genomics. Researchers in these settings use FISH probes for a wide range of applications, from studying basic biological processes to diagnosing genetic disorders. As research expands and diversifies, so does the market for FISH probes.

Key Market Challenges

Competitive Market Dynamics

Competition in the FISH Probe Market is fierce, with several major players and numerous smaller companies vying for market share. This competition can lead to price wars and pressure on profit margins. Differentiating products becomes crucial in this environment.

Key Market Trends

Expanding Applications in Non-Invasive Prenatal Testing (NIPT)

Non-invasive prenatal testing (NIPT) is revolutionizing prenatal care by allowing the detection of fetal chromosomal abnormalities through a simple blood test. FISH probes are becoming increasingly important in NIPT, enabling the identification of specific chromosomal disorders. The expansion of NIPT applications is expected to drive down the demand for FISH probes.

Key Market Players

• Thermo Fisher Scientific Inc.
• PerkinElmer Health Sciences Inc
• Biodot Inc
• New Horizons Diagnostic Corp
• Merck KGaA
• Agilent Technologies, Inc.
• Abnova Corp.
• Genemed Biotechnologies Inc
• F. Hoffmann-La Roche Ltd
• Oxford Gene Technology Ltd

Report Scope:

In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fluorescent In Situ Hybridization Probe Market, By Technology:

• Q FISH
• FLOW FISH
• Others

Fluorescent In Situ Hybridization Probe Market, By Type:

• DNA
• RNA
  • mRNA
  • miRNA
  • Others

Fluorescent In Situ Hybridization Probe Market, By Application:

• Cancer Research
• Genetic Diseases
• Others

Fluorescent In Situ Hybridization Probe Market, By End-Use:

• Research
• Clinical
• Companion Diagnostics

Fluorescent In Situ Hybridization Probe Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.

Available Customizations:

Global Fluorescent In Situ Hybridization Probe market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fluorescent In Situ Hybridization Probe Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Q FISH, FLOW FISH, Others)
  • 5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
  • 5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
  • 5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Product Market Map

6. North America Fluorescent In Situ Hybridization Probe Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-Use

7. Europe Fluorescent In Situ Hybridization Probe Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-Use
  • 7.3.2. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-Use
  • 7.3.3. France Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-Use

8. Asia-Pacific Fluorescent In Situ Hybridization Probe Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-Use
  • 8.3.2. Japan Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-Use
  • 8.3.3. India Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-Use
  • 8.3.4. Australia Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-Use
  • 8.3.5. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-Use

9. South America Fluorescent In Situ Hybridization Probe Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-Use
  • 9.3.2. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-Use
  • 9.3.3. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-Use

10. Middle East and Africa Fluorescent In Situ Hybridization Probe Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-Use
  • 10.3.3. UAE Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-Use
  • 10.3.4. Kuwait Fluorescent In Situ Hybridization Probe Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Technology
      • 10.3.4.2.2. By Type
      • 10.3.4.2.3. By Application
      • 10.3.4.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. PerkinElmer Health Sciences Inc
• 14.3. Biodot Inc
• 14.4. New Horizons Diagnostic Corp
• 14.5. Merck KGaA
• 14.6. Agilent Technologies, Inc.
• 14.7. Abnova Corp.
• 14.8. Genemed Biotechnologies Inc
• 14.9. F. Hoffmann-La Roche Ltd
• 14.10. Oxford Gene Technology Ltd

15. Strategic Recommendations

16. About Us & Disclaimer